Founded in July 2020, JNPMEDI has been putting effort on bringing disruption on healthcare industry via integrating digital technologies to clinical research & trial operations. With the launch of Maven CDMS™ and Maven clinical cloud solutions, we are taking steps forward to digitally transform the capabilities of regulatory authority, pharmaceuticals and CROs for better execution, management, monitoring, and audit of clinical trials.
JNPMEDI Inc. is consist of c-suite officers with experiences across the span of management consulting, digital transformation strategy, cutting-edge tech development, clinical operations and pharmaceuticals. We understand technologies as well as conventional clinical operations and delivering high performance to clinical ambiences to ultimately help general people in the globe. We propagate our core capabilities via operating divisions of R&D laboratory, business development, consulting and clinical operation support.
Company Details
- Employees
- 93
- Founded
- -
- Address
- Posco Tower, Conversia-Daero 165, Yeonsu-Gu, 31st Floor,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.jnpmedi.com
- Keywords
- CRO, Clinical Research, Clinical Cloud, Electronic Data Capture, Clinical Data Management System.
- HQ
- Incheon
Jnpmedi Questions
Jnpmedi's website is https://www.jnpmedi.com
Jnpmedi's LinkedIn profile is https://kr.linkedin.com/company/jnpmedi
Jnpmedi has
93 employees.
View email and phone details for 93
employees at Jnpmedi.
Jnpmedi's industry is
Pharmaceutical Manufacturing
Jnpmedi's top competitors are
Adm Korea Inc.,
Synex Consulting Ltd.,
Novotech,
Crscube Inc.,
C&r Research, Inc,
Iqvia,
Lsk Global Ps,
Lunit Cancer Screening,
Dreamcis,
Dt&cro.
Jnpmedi's categories are Pharmaceutical Manufacturing
Jnpmedi's founding year is 2020
